Both in R&D — Physical & Biological Sciences
bioAffinity Technologies vs iSpecimen
Over the past year BIAF returned −85.9% and ISPC returned −97.4%; their daily moves had a correlation of -0.04.
BIAF −85.9% ISPC −97.4%Growth of $1, one year, split-adjusted
| Metric | BIAF | ISPC |
|---|---|---|
| Price | $6.88 | $1.23 |
| Market cap | $4.1M | $3.1M |
| Today | −7.15% | +1.65% |
| 1 month | +41.3% | −20.1% |
| 6 months | −87.0% | −78.6% |
| Year to date | −61.1% | −88.2% |
| 1 year | −91.3% | −97.4% |
| Revenue growth (YoY) | +19.0% | −78.7% |
| Gross margin | 100.0% | 45.2% |
| Net margin | −222.8% | −896.9% |
| P/E (TTM) | — | — |
| Price / sales | 0.7× | 6.6× |
| Net cash | $1.8M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 823.5% | 97.3% |
| Short % of float | 0.9% | 14.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).